Suchergebnisse - "Robijns, Jolien"

1

Correction to: Barrier films and dressings for the prevention of acute Radiation dermatitis: A systematic review and meta-analysis

von: Robijns, Jolien

2023, in: Supportive care in cancer

Wird geladen...
2

Letter to the Editor concerning the article “Application of red light phototherapy in the treatment of radioactive dermatitis in patients with head and neck cancer”

von: Robijns, Jolien

2019, in: World journal of surgical oncology

Wird geladen...
3

A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial

von: Robijns, Jolien

2023, in: Supportive care in cancer

Wird geladen...
4

Natural and miscellaneous agents for the prevention of acute radiation dermatitis: a systematic review and meta-analysis

von: Robijns, Jolien

2023, in: Supportive care in cancer

Wird geladen...
5

Letter regarding “Same strategy for pitfalls of radiotherapy in different anatomical districts”

von: Robijns, Jolien

2016, in: Lasers in medical science

Wird geladen...
6

Evaluation of a novel skin care product for the management of chemotherapy–related dermatologic toxicities: A quasi-experimental study

von: Robijns, Jolien

2023, in: European journal of oncology nursing

Wird geladen...
7

Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)

von: Robijns, Jolien

2021, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...
8

Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients

von: Robijns, Jolien

2018, in: Supportive care in cancer

Wird geladen...
9

Response to the Comment on “Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)” by He et al.

von: Robijns, Jolien

2022, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...
10

The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature

von: Robijns, Jolien

2016, in: Lasers in medical science

Wird geladen...
11

Barrier Films and Dressings for the Prevention of Acute Radiation Dermatitis: A Systematic Review and Meta-Analysis

von: Robijns, Jolien

2023, in: Supportive care in cancer

Wird geladen...
12

Response to the Letter to the editor by Donnelly et al. regarding the article “Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)”

von: Robijns, Jolien

2021, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...
13

Response to the Comment on “Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)” by Baiocchi et al

von: Robijns, Jolien

2021, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...
14

Photobiomodulation for the management of radiation dermatitis: the DERMIS trial, a pilot study of $ MLS^{®} $ laser therapy in breast cancer patients

von: Censabella, Sandrine

2016, in: Supportive care in cancer

Wird geladen...
15

The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial)

von: Lodewijckx, Joy

2023, in: Supportive care in cancer

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!